Ostase® BAP EIA
- UID
- IMP/IVD/2023/000273_f35e385eae2f160c8fedbc887828035a_e63f394a906b6fa170adf27ca5082707
- Device class
- Class B
- Brand name
- IDS
- License holder
- Weldon Biotech India Pvt. Ltd
- Approving authority
- CDSCO
- Product information
- The Ostase® BAP EIA Immuno enzymetric Assay is an invitro device indicated for the quantitative measurement of bone-specific alkaline phosphatase (IDS), an indicator of osteoblastic activity, in human serum. This device is intended to be used as an aid in the management of postmenopausal osteoporosis and Paget’s disease
Ostase® BAP EIA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000273_f35e385eae2f160c8fedbc887828035a_e63f394a906b6fa170adf27ca5082707. This device is marketed under the brand name IDS. The license holder is Weldon Biotech India Pvt. Ltd, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.